Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

399 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Enrolling by invitation

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

NCT03999801

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations
  • Retinal Research Institute, LCC Phoenix, Arizona, United States
  • California Retina Consultants CRC Santa Barbara, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Ophthalmic Consultants of Boston Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Oral Metformin for Treatment of ABCA4 Retinopathy

NCT04545736

Conditions
ABCA4 Retinopathy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, not recruiting

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

NCT02402660

Conditions
Autosomal Recessive Stargardt Disease 1 (ABCA4-related), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Los Angeles, California, United States
  • Alkeus Site Aurora, Colorado, United States
  • Alkeus Site Gainesville, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

Conditions
Autosomal Recessive Stargardt Disease 1 (ABCA4-related), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations
  • Alkeus Site Phoenix, Arizona, United States
  • Alkeus Site Los Angeles, California, United States
  • Alkeus Site Aurora, Colorado, United States
  • Alkeus Site Gainesville, Florida, United States
View Trial Details
Active, not recruiting

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

NCT06018558

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Advanced Research, LLC Coral Springs, Florida, United States
  • Miidwest Eye Institute Carmel, Indiana, United States
  • Mississippi Retina Associates Jackson, Mississippi, United States
View Trial Details
Active, not recruiting

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

NCT05956626

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Associated Retina Consultants Phoenix, Arizona, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Vitreo Retinal Associates, P.A. Gainesville, Florida, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT06769048

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Associated Retina Consultants Gilbert, Arizona, United States
  • Associated Retina Consultants, Ltd. Phoenix, Arizona, United States
  • Cameron Ria, LLC Phoenix, Arizona, United States
  • Retina Macula Institute of Arizona Scottsdale, Arizona, United States
View all 44 locations
View Trial Details

Related conditions